Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
Noosa News23 hours agoFranz Ferdinand: Australian Tour 2025
-
General23 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
Noosa News16 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General16 hours agoDavid Littleproud’s own goal • Inside Story